市場調查報告書

腎臟癌治療藥的全球市場:2020年

Kidney Cancer Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 918134
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
腎臟癌治療藥的全球市場:2020年 Kidney Cancer Drugs Global Market Report 2020
出版日期: 2019年12月09日內容資訊: 英文
簡介

本報告提供全球腎臟癌治療藥市場的相關調查,提供市場趨勢及策略,市場成長及阻礙因素,類型·產品·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模及成長

  • 過去的市場
  • 市場預測
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 各類型:過去/預測
    • 腎細胞癌症(RCC)
    • 移行上皮細胞癌(TCC)/尿道表皮癌症(UCC)
  • 各產品:過去/預測
    • Nexavar
    • suten(Sunitinib)
    • Afinitor
    • Votrient(Pazopanib)
    • Avastin(Bevacizumab)
    • inrita(Axitinib ),
    • Temsirolimus(Torisel)
    • Proleukin(Aldesleukin)
    • 其他
  • 各終端用戶:過去/預測
    • 醫院
    • 診療所
    • 研究所
    • 其他

第5章 市場分析:各區各國

  • 市場過去/預測:各地區
  • 市場過去/預測:各國

第6章 亞太地區市場

  • 市場概要
  • 市場過去/預測:各類型
  • 市場過去/預測:各產品
  • 市場過去/預測:各終端用戶

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 競爭情形及企業簡介

  • 競爭情形
  • 企業簡介
    • Bayer AG
    • Pfizer Inc
    • Novartis International AG
    • Exelixis, Inc
    • F. Hoffmann-La Roche Ag

第26章主要的合併及收購

第27章 市場趨勢及策略

第28章 產品平台分析

第29章 市場今後的預測及潛在力分析

第30章 附錄

  • 簡稱
  • 貨幣
  • 調查相關諮詢方式
  • 商務調查企業
  • 著作權及免責聲明
目錄

Kidney Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global kidney cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the kidney cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Kidney Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC) 2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib),, Torisel (Temsirolimus), Proleukin (Aldesleukin), Others 3) By End Users: Hospitals, Clinics, Research Center, Others

Companies Mentioned: Bayer AG, Pfizer Inc, Novartis International AG, Exelixis, Inc, F. Hoffmann-La Roche Ag

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Kidney Cancer Drugs Market Characteristics

3. Kidney Cancer Drugs Market Size And Growth

  • 3.1. Global Kidney Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Kidney Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Kidney Cancer Drugs Market Segmentation

  • 4.1. Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Renal Cell Carcinoma (RCC)
    • Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC)
  • 4.2. Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Nexavar (Sorafenib)
    • Sutent (Sunitinib)
    • Afinitor (Everolimus)
    • Votrient (Pazopanib)
    • Avastin (Bevacizumab)
    • Inlyta (Axitinib),
    • Torisel (Temsirolimus)
    • Proleukin (Aldesleukin)
    • Others
  • 4.3. Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Research Center
    • Other

5. Kidney Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Kidney Cancer Drugs Market

  • 6.1. Asia-Pacific Kidney Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.4. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Kidney Cancer Drugs Market

  • 7.1. China Kidney Cancer Drugs Market Overview
  • 7.2. China Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.4. China Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Kidney Cancer Drugs Market

  • 8.1. India Kidney Cancer Drugs Market Overview
  • 8.2. India Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.4. India Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Kidney Cancer Drugs Market

  • 9.1. Japan Kidney Cancer Drugs Market Overview
  • 9.2. Japan Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.4. Japan Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Kidney Cancer Drugs Market

  • 10.1. Australia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.3. Australia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Kidney Cancer Drugs Market

  • 11.1. Indonesia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.3. Indonesia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Kidney Cancer Drugs Market

  • 12.1. South Korea Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.3. South Korea Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Kidney Cancer Drugs Market

  • 13.1. Western Europe Kidney Cancer Drugs Market Overview
  • 13.2. Western Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.4. Western Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Kidney Cancer Drugs Market

  • 14.1. UK Kidney Cancer Drugs Market Overview
  • 14.2. UK Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.4. UK Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Kidney Cancer Drugs Market

  • 15.1. Germany Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.3. Germany Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Kidney Cancer Drugs Market

  • 16.5. France Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.6. France Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.7. France Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Kidney Cancer Drugs Market

  • 17.1. Eastern Europe Kidney Cancer Drugs Market Overview
  • 17.2. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.4. Eastern Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Kidney Cancer Drugs Market

  • 18.1. Russia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.3. Russia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Kidney Cancer Drugs Market

  • 19.1. North America Kidney Cancer Drugs Market Overview
  • 19.2. North America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.4. North America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Kidney Cancer Drugs Market

  • 20.1. USA Kidney Cancer Drugs Market Overview
  • 20.2. USA Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.4. USA Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Kidney Cancer Drugs Market

  • 21.1. South America Kidney Cancer Drugs Market Overview
  • 21.2. South America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.4. South America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Kidney Cancer Drugs Market

  • 22.1. Brazil Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.3. Brazil Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Kidney Cancer Drugs Market

  • 23.1. Middle East Kidney Cancer Drugs Market Overview
  • 23.2. Middle East Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.4. Middle East Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Kidney Cancer Drugs Market

  • 24.1. Africa Kidney Cancer Drugs Market Overview
  • 24.2. Africa Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.4. Africa Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Kidney Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Kidney Cancer Drugs Market Competitive Landscape
  • 25.2. Kidney Cancer Drugs Market Company Profiles
    • 25.2.1. Bayer AG
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Pfizer Inc
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis International AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Exelixis, Inc
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. F. Hoffmann-La Roche Ag
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Kidney Cancer Drugs Market

27. Kidney Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Kidney Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top